Skip to main content
. Author manuscript; available in PMC: 2024 Oct 28.
Published in final edited form as: AIDS. 2017 Mar 27;31(6):745–752. doi: 10.1097/QAD.0000000000001389

Fig. 1. Protection by vaginal TFV gel in macaques coinfected with Chlamydia trachomatis/Trichomonas vaginalis.

Fig. 1.

TFV, tenofovir. Kaplan–Meier plot representing the cumulative percentage of uninfected macaques as a function of the number of months or menstrual cycles. Chlamydia trachomatis/Trichomonas vaginalis coinfected macaques were challenged twice weekly with simian HIV (50 TCID) for up to 10 weeks followed by a 10-week washout period. Each survival curve represents the cumulative percentage of uninfected macaques treated with placebo gel (solid grey) or TFV gel 30 min (solid black) or 3 days (dotted black) before each challenge. Black arrows denote SHIV challenges and dotted vertical lines represent boost Chlamydia trachomatis/Trichomonas vaginalis inoculations.